US Patent Issued to UNIVERSITETET I OSLO on Nov. 11 for "ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases" (Norwegian, Swiss Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,607, issued on Nov. 11, was assigned to UNIVERSITETET I OSLO (Oslo, Norway).

"ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases" was invented by Hesso Farhan (Oslo, Norway), Ludvig Munthe (Fjellhamar, Norway), Kjetil Tasken (Rykkinn, Norway), Sigrid Skanland (Oslo, Norway), Mariaserena Giliberto (Oslo, Norway), Fredrik Hellem Schjesvold (Jar, Norway), Christoph Driessen (St. Gallen, Switzerland), Lenka Besse (St. Gallen, Switzerland) and Andrej Besse (St. Gallen, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method of treating ALK-negative/LTK-positive cancer in a subj...